Login
Toggle navigation
Videos
Categories
Trending
Unlocking the potential of your asset management business.|Mathias Österberg, CEO, GRIT Governance
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Mathias Österberg is the CEO of GRIT Governance.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
When to Build a Venture-Backed Startup|Darian Shirazi,General Partner, Gradient Ventures
00:10:00
Real-Time Payments Discussion: Mastercard Perspectives | Craig Ramsey - Head of Real-Time Payments of ACI Worldwide
00:00:00
Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic
00:10:00
Unlocking Growth in Asian Property Markets: Insights from Sarah Lien of Eastspring Investments | Sarah Lien - Client Portfolio Manager, Eastspring Investments
00:10:00
PROVIDES BREAKTHROUGH ONCOLOGICAL DRUG CANDIDATES|JOHAN EMILSSON, Chief Executive Officer,Sprint Bioscience
00:10:00
An interview with Aferian plc CEO Donald McGarva | Donald McGarva, CEO, Aferian PLCAFRN:LSE
00:10:00
Rick Rule Interviews Brian Dalton on Altus Minerals' Success and Future
00:10:00
Marinemine: Focused on Lithium and Gold Exploration in Western Australia
00:10:00
Navigating European High Yield Bonds: Madelaine Jones' Insights on Bloomberg Markets (2022)
00:10:00
Unlocking Value: EMX's Strategic Royalties and Copper-Gold Assets
00:10:00
Power Dynamics: Interview with Aboitiz Power President & CEO | Manny Rubio , CEO, Aboitiz Power Corp.
00:10:00
New Range Gold Corp. Acquires Argosy Gold Mine in Red Lake District, Ontario